Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1072 of 1,261
  1. US 7304061

    Heterocyclic inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  2. US 7303881

    Antigen delivery compositions and methods of use

    PDS Biotechnology Corporation · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  3. US 7303754

    MVA expressing modified HIV envelope, gag, and pol genes

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  4. US 7303751

    Anti-plasmodium compositions and methods of use

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  5. US 7303748

    Method of treating eye injury with local administration of a VEGF inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  6. US 7303887

    Mule: Mcl-1 ubiquitination ligase E3

    The Board of Regents of the University of Texas System · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  7. US 7303746

    Methods of treating eye disorders with modified chimeric polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  8. US 7303747

    Use of VEGF inhibitors for treatment of eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  9. US 7304071

    Protein kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  10. US 7300915

    Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain

    The Regents of the University of California · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  11. US 7300650

    Reovirus for the treatment of neoplasia

    ONCOLYTICS BIOTECH INC. · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  12. US 7300653

    Method of treating corneal transplant rejection

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  13. US 7300654

    Method of treating corneal transplant rejection in high risk keratoplasty patients

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  14. US 7300919

    Pulmonary delivery of active fragments of parathyroid hormone

    Nektar Therapeutics · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  15. US 7300920

    Antiangiogenic peptide agents

    The Regents of the University of California · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  16. US 7300774

    Multimeric fusion proteins of the TNF superfamily ligands

    The Regents of the University of California · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  17. US 7300928

    Benzimidazolidinone derivatives as muscarinic agents

    ACADIA Pharmaceuticals Inc. · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  18. US 7300949

    Thiazolopyrazoles and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  19. US 7301024

    Crystalline forms of gatifloxacin and processes for preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  20. US 7301004

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  21. US 7300935

    Thienopyrimidine compounds and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  22. US 7300660

    Abundant extracellular products and methods for their production and use

    The Regents of the University of California · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  23. US 7300940

    Integrin α-v β-3 antagonists for use in imaging and therapy

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  24. US 7297523

    Human elongase genes and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Nov 20, 2007 · Expires Nov 15, 2027

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.